Literature DB >> 19148719

Permanent pacemaker implantation via left superior vena cava without communication with the coronary sinus.

Umashankar Lakshmanadoss1, Edward Goldstein, Abrar H Shah.   

Abstract

The persistence of the left superior vena cava is a rare venous anomaly and usually does not produce hemodynamic disturbances. Left sided cardiac device implantation has increased the awareness of this rare anomaly. In most cases, left superior vena cava connects to the right heart via coronary sinus. We describe a rare case of successful permanent pacemaker implantation via left superior vena cava-accessory hemiazygos-hemiazygos-inferior vena caval communication.

Entities:  

Mesh:

Year:  2009        PMID: 19148719     DOI: 10.1007/s10840-008-9347-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  6 in total

1.  An anatomical study of the human cardiac veins with special reference to the drainage of the great cardiac vein.

Authors:  Tomokazu Kawashima; Kenji Sato; Fumi Sato; Hiroshi Sasaki
Journal:  Ann Anat       Date:  2003-12       Impact factor: 2.698

2.  [Persistent left superior vena cava and mitral stenosis].

Authors:  M ALBERT; W GEISSLER
Journal:  Z Gesamte Inn Med       Date:  1956-10-01

3.  Unexpected persistent left superior vena cava: diagnostic clues during monitoring.

Authors:  J C Horrow; N Lingaraju
Journal:  J Cardiothorac Anesth       Date:  1989-10

4.  Persistent left superior vena cava-inferior vena caval communication complicating implantation of an implantable cardioverter defibrillator.

Authors:  Sanjeev Goyal; Lawrence Rosenthal
Journal:  Pacing Clin Electrophysiol       Date:  2005-11       Impact factor: 1.976

5.  Implication of a persistent left superior vena cava in transvenous pacemaker therapy and cardiac hemodynamic monitoring.

Authors:  M Rubenfire; J Evangelista; W J Wajszczuk; A Kantrowitz
Journal:  Chest       Date:  1974-02       Impact factor: 9.410

6.  Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience.

Authors:  M Biffi; G Boriani; L Frabetti; G Bronzetti; A Branzi
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.